Xi'an Xintong Pharmaceutical Research Co.,ltd.

This study tests a new oral medication, hepenofovir fumarate, for people with chronic hepatitis B. It involves 1444 adults aged 18-65 who have not been treated before or have stopped treatment. The goal is to find the best dose that controls the virus safely, compared to an exist…

This study tests a new drug called pracytarabine against a standard drug (regorafenib) in 60 adults with advanced liver cancer that has not responded to previous targeted therapy and immunotherapy. The goal is to see if pracytarabine helps patients live longer or slows cancer gro…